{"cik":1710072,"taxonomy":"us-gaap","tag":"OtherLiabilitiesNoncurrent","label":"Other Liabilities, Noncurrent","description":"Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.","entityName":"Edgewise Therapeutics, Inc.","units":{"USD":[{"end":"2021-09-30","val":295000,"accn":"0001558370-21-015395","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-10","frame":"CY2021Q3I"},{"end":"2021-12-31","val":329000,"accn":"0001558370-22-001850","fy":2021,"fp":"FY","form":"10-K","filed":"2022-02-24"},{"end":"2021-12-31","val":329000,"accn":"0001558370-22-008235","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-11"},{"end":"2021-12-31","val":329000,"accn":"0001558370-22-012067","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-04"},{"end":"2021-12-31","val":329000,"accn":"0001558370-22-016149","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-03"},{"end":"2021-12-31","val":329000,"accn":"0001558370-23-001895","fy":2022,"fp":"FY","form":"10-K","filed":"2023-02-23","frame":"CY2021Q4I"},{"end":"2022-03-31","val":187000,"accn":"0001558370-22-008235","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-11","frame":"CY2022Q1I"},{"end":"2022-06-30","val":192000,"accn":"0001558370-22-012067","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-04","frame":"CY2022Q2I"},{"end":"2026-09-30","val":888000,"accn":"0001104659-26-122653","fy":2026,"fp":"Q3","form":"10-Q","filed":"2026-11-04","frame":"CY2026Q3I"}]}}